Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia-Reference-Cited by-同舟云学术

Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia

Published:2017-10-20 Issue:6 Volume:38 Page:1000-1009
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Aberra Hanna¹,Gordien Emmanuel²,Desalegn Hailemichael¹,Berhe Nega³⁴,Medhin Girmay³,Mekasha Bitsatab¹,Gundersen Svein G.⁵⁶,Gerber Athenaïs²,Stene-Johansen Kathrine⁷,Øverbø Joakim⁸,Johannessen Asgeir⁴^ORCID

Affiliation:

1. Medical Department; St. Paul's Hospital Millennium Medical College; Addis Ababa Ethiopia

2. Centre National de Référence des Hépatites B, C et Delta; Hôpitaux Universitaires Paris- Seine-Saint-Denis; Paris Bobigny France

3. Aklilu Lemma Institute of Pathobiology; Addis Ababa University; Addis Ababa Ethiopia

4. Centre for Imported and Tropical Diseases; Oslo University Hospital, Ullevål; Oslo Norway

5. Research Unit; Sørlandet Hospital HF; Kristiansand Norway

6. Department of Global Development and Planning; University of Agder; Kristiansand Norway

7. Department of Molecular Biology; Norwegian Institute of Public Health; Oslo Norway

8. Department of Vaccine Preventable Diseases; Norwegian Institute of Public Health; Oslo Norway

Funder

Norges Forskningsråd

Helse Sør-Øst RHF

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13607/fullpdf

Reference33 articles.

1. WHO Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection Geneva World Health Organization 2015

2. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead;Wedemeyer;Nat Rev Gastroenterol Hepatol,2010

3. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma;Romeo;Gastroenterology,2009

4. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

5. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial;Koh;Lancet Infect Dis,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis delta virus;Treatment and Management of Tropical Liver Disease;2025

2. Viral Hepatitis in Travellers;Emerging and Re-emerging Infections in Travellers;2024

3. Changing Trends in the Epidemiology of Delta Virus Infection;Viral Hepatitis Journal;2023-07-21

4. Magnitude and genotype of hepatitis delta virus among chronic hepatitis B carriers with a spectrum of liver diseases in Ethiopia;Annals of Hepatology;2023-01

5. Low seroprevalence of hepatitis delta virus co-infection in hepatitis B virus-infected blood donors in China: A multicenter study;Frontiers in Microbiology;2022-11-14